Technical Analysis for 0Q77 - AB Science S.A.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -3.68% | |
| Narrow Range Bar | Range Contraction | -3.68% | |
| Wide Bands | Range Expansion | -3.68% | |
| Oversold Stochastic | Weakness | -3.68% |
| Alert | Time |
|---|---|
| Bearish 180 Entry | 3 days ago |
| Fell Below Previous Day's Low | 3 days ago |
| 3x Volume Pace | 3 days ago |
| 2x Volume Pace | 3 days ago |
| 1.5x Volume Pace | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Classification
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.16 |
| 52 Week Low | 1.566 |
| Average Volume | 4,892 |
| 200-Day Moving Average | 2.92 |
| 50-Day Moving Average | 2.50 |
| 20-Day Moving Average | 2.19 |
| 10-Day Moving Average | 2.05 |
| Average True Range | 0.08 |
| RSI (14) | 27.54 |
| ADX | 32.1 |
| +DI | 19.73 |
| -DI | 57.26 |
| Chandelier Exit (Long, 3 ATRs) | 2.43 |
| Chandelier Exit (Short, 3 ATRs) | 2.12 |
| Upper Bollinger Bands | 2.58 |
| Lower Bollinger Band | 1.81 |
| Percent B (%b) | 0.1 |
| BandWidth | 35.11 |
| MACD Line | -0.16 |
| MACD Signal Line | -0.15 |
| MACD Histogram | -0.0135 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.88 | ||||
| Resistance 3 (R3) | 1.88 | 1.88 | 1.88 | ||
| Resistance 2 (R2) | 1.88 | 1.88 | 1.88 | 1.88 | |
| Resistance 1 (R1) | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
| Pivot Point | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
| Support 1 (S1) | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
| Support 2 (S2) | 1.88 | 1.88 | 1.88 | 1.88 | |
| Support 3 (S3) | 1.88 | 1.88 | 1.88 | ||
| Support 4 (S4) | 1.88 |
